348 related articles for article (PubMed ID: 25517075)
1. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of diabetes pay-for-performance incentive designs.
Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
[TBL] [Abstract][Full Text] [Related]
3. Does medication adherence lead to lower healthcare expenses for patients with diabetes?
Cheng SH; Chen CC; Tseng CH
Am J Manag Care; 2013 Aug; 19(8):662-70. PubMed ID: 24304214
[TBL] [Abstract][Full Text] [Related]
4. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
[TBL] [Abstract][Full Text] [Related]
5. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.
Lee TT; Cheng SH; Chen CC; Lai MS
Am J Manag Care; 2010 Jan; 16(1):65-9. PubMed ID: 20148607
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment.
Cheng SH; Lee TT; Chen CC
Med Care; 2012 Feb; 50(2):109-16. PubMed ID: 22249920
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database.
Chen HL; Hsiao FY
J Diabetes Complications; 2014; 28(5):612-6. PubMed ID: 25037987
[TBL] [Abstract][Full Text] [Related]
8. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
11. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
12. Continuity of ambulatory care and health outcomes in adult patients with type 2 diabetes in Korea.
Hong JS; Kang HC
Health Policy; 2013 Feb; 109(2):158-65. PubMed ID: 23093021
[TBL] [Abstract][Full Text] [Related]
13. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
Drabik A; Graf C; Büscher G; Stock S
Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
[TBL] [Abstract][Full Text] [Related]
14. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
15. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
[TBL] [Abstract][Full Text] [Related]
16. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
Tan EC; Pwu RF; Chen DR; Yang MC
Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
[TBL] [Abstract][Full Text] [Related]
17. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
[TBL] [Abstract][Full Text] [Related]
18. Better continuity of care reduces costs for diabetic patients.
Chen CC; Chen SH
Am J Manag Care; 2011 Jun; 17(6):420-7. PubMed ID: 21756012
[TBL] [Abstract][Full Text] [Related]
19. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
20. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
